A Salvage Trial of AR Inhibition with ADT and Apalutamide with Docetaxel followed by Radiation Therapy in Men with PSA Recurrent Prostate Cancer after Radical Prostatectomy (¿STARTAR¿)
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Janssen Pharmaceutica, Inc.
Start Date
March 8, 2018
End Date
February 28, 2023
Administered By
Duke Cancer Institute
Awarded By
Janssen Pharmaceutica, Inc.
Start Date
March 8, 2018
End Date
February 28, 2023